← Back to the catalogue
Lipoproteins and apolipoproteins
IDL
Intermediate-density lipoprotein, a product of VLDL catabolism and precursor of LDL; reported through its cholesterol and triglycerides.
Application contexts
- Cardiometabolic health
Matrices
- Serum or plasma
Related techniques
- ¹H-NMR
- Ultracentrifugation
Reported parameters
Each parameter is quantified by ¹H-NMR in serum or plasma and appears in the report with this code and unit.
ParameterCodeUnit
Cholesterol
IDL cholesterol
IDL-C mg/dL Triglycerides
IDL triglycerides
IDL-TG mg/dL Ratios
IDL triglyceride-to-cholesterol ratio
IDL-TG/IDL-C — Related publications
- Chronic kidney disease induces a distinct lipidomic signature and accelerates atherosclerosis progression in a novel minipig model. 2026 · Laboratory animal research · 1 citation
Related news
- Menopause and cardiovascular health: looking beyond traditional risk factors 20 October 2026 · Panel: NMR lipoprotein profiling
- World Heart Day 2026: Prevention and Cardiovascular Risk 27 September 2026 · Panel: NMR lipoprotein profiling
- Familial Hypercholesterolemia: The Importance of Early Detection 22 September 2026 · Panel: NMR lipoprotein profiling
Show 40 more Show less
- Icosapent ethyl and residual cardiovascular risk: what NMR reveals beyond triglycerides 16 September 2026 · Panel: NMR lipoprotein profiling
- La Tríada Aterogénica: El Fenotipo de Riesgo en el Paciente Metabólico 27 January 2026 · in Spanish · Panel: NMR lipoprotein profiling
- The Lipid Silhouette: A Visual Snapshot of Cardiovascular Risk in the Liposcale Report 20 January 2026 · Panel: NMR lipoprotein profiling
- The Number of LDL Particles: The Hidden Metric That Explains True Atherosclerotic Risk in Dyslipidemia 13 January 2026 · Panel: NMR lipoprotein profiling
- Obesity Affects Men and Women Differently: New Insights into the Lipoprotein Profile 10 November 2025 · Panel: NMR lipoprotein profiling
- Triglycerides: More Than a Marker — A Driver of Cardiovascular Risk 14 October 2025 · Panel: NMR lipoprotein profiling
- ASCAHIFA and Biosfer Teslab on Familial Hypercholesterolemia Day 17 September 2025 · Panel: NMR lipoprotein profiling
- When LDL Cholesterol Doesn’t Tell the Whole Story: A Clinical Case of Hidden Cardiovascular Risk 13 May 2025 · Panel: NMR lipoprotein profiling
- NMR Metabolomics in Animal Models: A Key Tool for Translational Research 10 April 2025 · Panel: NMR lipoprotein profiling
- Liposcale and Glycoscale in Cardiovascular Risk Prediction in Type 2 Diabetes 25 March 2025 · Panel: NMR lipoprotein profiling
- Beyond LDL: A Comprehensive Approach to Cardiovascular Health 13 March 2025 · Panel: NMR lipoprotein profiling
- Nutrition and Cardiovascular Health: Reflections on World Food Day 16 October 2024 · Panel: NMR lipoprotein profiling
- Familial Hypercholesterolemia and the Importance of Metabolomics for Its Detection and Personalized Treatment 24 September 2024 · Panel: NMR lipoprotein profiling
- Role of Metabolomics in Infectious Diseases: A Cross-sectional Approach 19 September 2024 · Panel: NMR lipoprotein profiling
- Importance of LDL Cholesterol in Bariatric Surgery Techniques 02 July 2024 · Panel: NMR lipoprotein profiling
- Cardiovascular Risk in Lupus Patients through NMR 30 April 2024 · Panel: NMR lipoprotein profiling
- Desvelando Misterios de la Complejidad Lipoproteica en Diabetes Tipo 2 y Riesgo Cardiovascular 29 April 2024 · in Spanish · Panel: NMR lipoprotein profiling
- Neurodegenerative Diseases: Metabolomics to Reveal Biomarkers for Early Diagnosis 11 April 2024 · Panel: NMR lipoprotein profiling
- Liposcale Test: Use Cases 09 April 2024 · Panel: NMR lipoprotein profiling
- Understanding the Impact of Bariatric Surgery on Dyslipidemia and Cardiovascular Risk Reduction 02 April 2024 · Panel: NMR lipoprotein profiling
- Biosfer Teslab at the forefront of NMR sample analysis 26 March 2024 · Panel: NMR lipoprotein profiling
- Breakthrough in Mediterranean Diet Research for Metabolic Syndrome Patients 19 February 2024 · Panel: NMR lipoprotein profiling
- Exploring Metabolomics through Nuclear Magnetic Resonance and its Impact on Nutritional Interventions 13 February 2024 · Panel: NMR lipoprotein profiling
- What does metabolomics contribute to HIV research? 30 November 2023 · Panel: NMR lipoprotein profiling
- Glycoproteins: Emerging Markers of Inflammation 20 November 2023 · Panel: NMR lipoprotein profiling
- What is metabolomics and how is it applied in diabetes? 13 November 2023 · Panel: NMR lipoprotein profiling
- Discordance between LDL-C levels and LDL particle number 23 October 2023 · Panel: NMR lipoprotein profiling
- Cardiovascular Disease: Beyond LDL Cholesterol 16 October 2023 · Panel: NMR lipoprotein profiling
- Biosfer Teslab launches MetBalance Test 04 October 2022 · Panel: NMR lipoprotein profiling
- Our lipoprotein and glycoprotein test in the SEA conference 04 April 2022 · Panel: NMR lipoprotein profiling
- Metabolomics arrives at “The liver Meeting” comes from Biosfer Teslab 25 November 2021 · Panel: NMR lipoprotein profiling
- Barça Innovation Hub: Metabolomics at the forefront of elite sport 16 November 2021 · Panel: NMR lipoprotein profiling
- Liposcale for early and reliable diagnosis and prognosis of breast cancer patients 08 September 2021 · Panel: NMR lipoprotein profiling
- Liposcale in Circulation 01 September 2021 · Panel: NMR lipoprotein profiling
- Improvement in the prediction of atheromatous cardiovascular disease using the Liposcale test 20 July 2021 · Panel: NMR lipoprotein profiling
- The use of Liposcale® Test in Premature Cardiovascular disease 06 April 2021 · Panel: NMR lipoprotein profiling
- Our Liposcale test in clinical practice 13 October 2020 · Panel: NMR lipoprotein profiling
- LDL cholesterol: the poison is stored in small bottles 26 October 2018 · Panel: NMR lipoprotein profiling
- Standard values of number and size of lipoprotein particles per age and gender, using Nuclear Magnetic Resonance 27 July 2016 · Panel: NMR lipoprotein profiling
- Especialists ask for the use in clinical practise of the new Lipoprotein determination test 20 July 2016 · Panel: NMR lipoprotein profiling
Related projects
- AVANTE 2023 · Consortium coordinator · Panel: NMR lipoprotein profiling
- COST Action AtheroNET 2022 · Consortium partner · Panel: NMR lipoprotein profiling
- CARDIOSCOPE 2022 · Consortium partner · Panel: NMR lipoprotein profiling
Show 8 more Show less
- Companion diagnostic for Saroglitazar 2021 · Beneficiary company · Panel: NMR lipoprotein profiling
- VISIONING 2021 · Co-principal investigator, with the IRB CatSud metabolomics platform · Panel: NMR lipoprotein profiling
- Torres Quevedo · Diagnostic metabolomics 2020 · Beneficiary company · Panel: NMR lipoprotein profiling
- ANDINA NMR 2019 · Beneficiary company · Panel: NMR lipoprotein profiling
- Cardiometabolic prediction 2018 · Beneficiary company · Panel: NMR lipoprotein profiling
- NEOTEC 2017 · Beneficiary company · Panel: NMR lipoprotein profiling
- Nuclis RD15-1-0013 2016 · Beneficiary company · Panel: NMR lipoprotein profiling
- Torres Quevedo · Cardiovascular risk 2014 · Beneficiary company · Panel: NMR lipoprotein profiling